Slinkman David 4
4 · QUAKER CHEMICAL CORP · Filed May 16, 2023
Insider Transaction Report
Form 4
Slinkman David
SVP - Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-15$136.64/sh+2,341$319,874→ 7,023 total - Sale
Common Stock
2023-05-15$204.20/sh−736$150,294→ 4,682 total - Sale
Common Stock
2023-05-15$204.20/sh−2,341$478,040→ 4,682 total - Sale
Common Stock
2023-05-15$204.20/sh−606$123,747→ 4,682 total - Exercise/Conversion
Common Stock
2023-05-15$178.29/sh+606$108,044→ 5,288 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-05-15−2,341→ 0 totalExercise: $136.64Exp: 2027-03-30→ Common Stock (2,341 underlying) - Exercise/Conversion
Common Stock
2023-05-15$154.92/sh+736$114,021→ 5,418 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-05-15−736→ 0 totalExercise: $154.92Exp: 2026-02-25→ Common Stock (736 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-05-15−606→ 1,213 totalExercise: $178.29Exp: 2029-03-16→ Common Stock (606 underlying)
Holdings
- 62(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Information based on reporting person's Plan Statement as of March 31, 2023.
- [F2]The options for this grant vested in three annual installments: 737 shares on February 25, 2020; 737 shares on February 25, 2021; and 736 shares on February 25, 2022.
- [F3]The options for this grant vested in three annual installments: 781 shares on March 30, 2021; 780 shares on March 30, 2022; and 780 shares on March 30, 2023.
- [F4]The options for this grant vest in three annual installments: 606 shares on March 16, 2023; 606 shares on March 16, 2024; and 607 shares on March 16, 2025.